- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... AI and modern legal technology tools Scientific background and familiarity beyond pure legal experience Nice-to-Haves Experience working with Chinese pharmaceutical… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Bayer (New York, NY)
- …Identify and recommend TLs to provide brand insight and execute peer-to-peer programs beyond their own practice; Create a deeper relationship with these customers by ... engaging with across different channels and activities (conferences, advisory boards, consulting, speaker’s bureau, etc.); Collaborate with field teams to identify key KOLs / stakeholders to engage whilst maintaining a focus on the highest target / influential… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
- Formation Bio (New York, NY)
- …organizations, and biotechs to develop programs past clinical proof of concept and beyond , ultimately helping to bring new medicines to patients. The company is ... backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: Our Vision for AI in Pharma Our Current Drug Portfolio… more
